In a potential game-changer for millions of Americans, drugs like Ozempic and Wegovy—commonly used for weight loss and diabetes management—could soon be covered by Medicare.
The drugs were included in a recent list of 16 medications selected for price negotiations between the government and their manufacturers. This development could make these treatments more accessible to the many people who rely on them.
According to Dr. Cate Varney, an obesity management specialist, the impact of including such medications under Medicare would be significant, particularly for those struggling with the high cost of treatment. “Cost is a major barrier for many patients, both in starting and maintaining their use of these medications,” Dr. Varney explained. “Studies have shown that the financial burden is a key factor in patient adherence to these drugs.”
While Ozempic is primarily prescribed for managing type 2 diabetes, it also has a range of other health benefits, including reducing the risk of heart disease and improving kidney health. Though not originally intended for weight loss, Ozempic has become increasingly popular for its ability to aid in weight management.
Dr. Varney noted that approximately 20% of all medications in the U.S. are used for “off-label” purposes, including Ozempic, whose weight loss benefits have been recognized beyond its primary use for blood sugar control.
Despite its benefits, Dr. Varney urged caution regarding the growing number of third-party websites selling similar weight loss drugs. She emphasized that it’s safest to obtain these medications through a licensed medical provider. “Medications prescribed by healthcare professionals are rigorously tested by the FDA for both safety and efficacy,” she stated.
However, Dr. Varney cautioned that these medications should not be seen as a quick fix. She stressed that lifestyle changes—such as a balanced diet and regular physical activity—remain essential for the drugs to work effectively. “These medications are most successful when combined with lifestyle changes,” she said. “It’s always important to consult with a healthcare provider to find the best approach tailored to your needs.”
Related topics:
New Study Uncovers Key Molecular Pathway in Progression from Gestational Diabetes to Type 2 Diabetes
Air Pollution Exposure Linked to Increased Risk of Type 2 Diabetes, Study Shows
